Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Henry ScheinHSIC +0.68%81 3-1 Month Momentum % is 11.97% as of Aug. 02, 2026. GuruFocus rates HSIC with a GF Score™ of 81/100 and a GF Value™ of $84.22 (Fairly Valued). The stock has 9 warning signs investors should review. Among 119 Medical Distribution companies, Henry Schein ranks better than 86.55% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-02), Henry Schein's 3-1 Month Momentum % is 11.97%.
The industry rank for Henry Schein's 3-1 Month Momentum % or its related term are showing as below:
HSIC's 3-1 Month Momentum % is ranked better than 86.55% of 119
companies
in the Medical Distribution industry
Industry Median: -8.13
vs HSIC: 11.97
Henry Schein (NAS:HSIC) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Henry Schein 3-1 Month Momentum % Related Terms
HSIC vs AHG, ACH, FOCL: 3-1 Month Momentum % Comparison
For the Medical Distribution subindustry, Henry Schein's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein 3-1 Month Momentum % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Henry Schein's 3-1 Month Momentum % falls into.
Henry Schein (NAS:HSIC) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henry Schein (HSIC) has a 3-1 Month Momentum % of 11.97% as of Aug. 02, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Henry Schein and its competitors. According to the industry distribution chart, Henry Schein ranks #16 out of 119 companies in the Medical Distribution industry, placing it in the top 13.4%.
Is Henry Schein's 3-1 Month Momentum % too high?
Henry Schein's current 3-1 Month Momentum % is 11.97%. Based on the distribution chart, Henry Schein ranks #16 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Henry Schein has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's 3-1 Month Momentum % compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #16 out of 119 companies for 3-1 Month Momentum %. This places Henry Schein in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Distribution company?
A good 3-1 Month Momentum % depends on the Medical Distribution industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Henry Schein and its competitors. Henry Schein's current 3-1 Month Momentum % is 11.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $84.22, compared to a current price of $85.75 — trading 1.8% above its estimated fair value. The current 3-1 Month Momentum % is 11.97%. Henry Schein's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Henry Schein (HSIC), the current 3-1 Month Momentum % is 11.97% as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $85.75 is trading 1.8% above its estimated GF Value™ of $84.22.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
3-1 Month Momentum %: 11.97%
GF Value™: $84.22 vs. price of $85.75 (1.8% above fair value)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
81GF Score
Get the complete analysis for HSIC
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
